Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Privia Health Group (PRVA) 10K Form and Latest SEC Filings 2026

Privia Health Group logo
$22.64 -0.54 (-2.33%)
Closing price 04:00 PM Eastern
Extended Trading
$22.64 0.00 (-0.02%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Privia Health Group SEC Filings & Recent Activity

Privia Health Group (NASDAQ:PRVA) has submitted 381+ documents to the U.S. Securities and Exchange Commission (SEC) since 2019. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Privia Health Group's financial statements. The most recent filing was a Form 4 submitted on May 13, 2026.

Form 4
Privia Health Group, Inc. Reports Ownership Change on May. 13, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Privia Health Group Files Current Report on May. 7, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Privia Health Group Files Quarterly Report on May. 7, 2026

The 10-Q contains Privia Health Group's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Privia Health Group SEC Filing History

Browse Privia Health Group's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/13/2026 6:40 PM
Mehrotra Parth (1858398) Reporting
Privia Health Group (1759655) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2026 5:10 PM
Mountcastle David (1858396) Reporting
Privia Health Group (1759655) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2026 9:24 AM
Mehrotra Parth (1858398) Reporting
Privia Health Group (1759655) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/11/2026 3:21 PM
Mehrotra Parth (1858398) Reporting
Privia Health Group (1759655) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/11/2026 2:29 PM
Mountcastle David (1858396) Reporting
Privia Health Group (1759655) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/11/2026 2:18 PM
Mehrotra Parth (1858398) Reporting
Privia Health Group (1759655) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2026 7:58 AM
Privia Health Group (1759655) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2026 5:07 AM
Privia Health Group (1759655) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2026 7:07 PM
Mountcastle David (1858396) Reporting
Privia Health Group (1759655) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2026 5:10 PM
Morris Matthew Shawn (1401958) Reporting
Privia Health Group (1759655) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2026 3:34 PM
Mountcastle David (1858396) Reporting
Privia Health Group (1759655) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/01/2026 3:46 PM
Morris Matthew Shawn (1401958) Reporting
Privia Health Group (1759655) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/01/2026 3:47 PM
Mountcastle David (1858396) Reporting
Privia Health Group (1759655) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/29/2026 1:44 PM
Privia Health Group (1759655) Subject
VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by
Form SCHEDULE 13G
04/02/2026 3:58 PM
Mountcastle David (1858396) Reporting
Privia Health Group (1759655) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/02/2026 6:59 AM
Privia Health Group (1759655) Filer
Form DEFA14A
04/02/2026 7:01 AM
Privia Health Group (1759655) Filer
Form ARS
04/02/2026 6:55 AM
Privia Health Group (1759655) Filer
Form DEF 14A
03/27/2026 10:20 AM
Privia Health Group (1759655) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/16/2026 3:04 PM
Mehrotra Parth (1858398) Reporting
Privia Health Group (1759655) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/16/2026 2:50 PM
Mountcastle David (1858396) Reporting
Privia Health Group (1759655) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2026 3:46 PM
Mehrotra Parth (1858398) Reporting
Privia Health Group (1759655) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2026 4:46 PM
Mountcastle David (1858396) Reporting
Privia Health Group (1759655) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2026 4:46 PM
Fargis Edward C (2009323) Reporting
Privia Health Group (1759655) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2026 4:47 PM
Mehrotra Parth (1858398) Reporting
Privia Health Group (1759655) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2026 3:14 PM
Mountcastle David (1858396) Reporting
Privia Health Group (1759655) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/09/2026 3:23 PM
Mehrotra Parth (1858398) Reporting
Privia Health Group (1759655) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/09/2026 3:17 PM
Mehrotra Parth (1858398) Reporting
Privia Health Group (1759655) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/09/2026 2:58 PM
Mountcastle David (1858396) Reporting
Privia Health Group (1759655) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2026 2:42 PM
Mountcastle David (1858396) Reporting
Privia Health Group (1759655) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2026 2:44 PM
Mehrotra Parth (1858398) Reporting
Privia Health Group (1759655) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/02/2026 4:22 PM
Mountcastle David (1858396) Reporting
Privia Health Group (1759655) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2026 4:23 PM
Morris Matthew Shawn (1401958) Reporting
Privia Health Group (1759655) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2026 3:38 PM
Mountcastle David (1858396) Reporting
Privia Health Group (1759655) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2026 7:12 AM
Privia Health Group (1759655) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2026 5:05 AM
Privia Health Group (1759655) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2025 3:37 PM
Mountcastle David (1858396) Reporting
Privia Health Group (1759655) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2025 3:38 PM
Morris Matthew Shawn (1401958) Reporting
Privia Health Group (1759655) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2025 5:31 PM
Morris Matthew Shawn (1401958) Reporting
Privia Health Group (1759655) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2025 3:38 PM
Mountcastle David (1858396) Reporting
Privia Health Group (1759655) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/08/2025 7:01 AM
Privia Health Group (1759655) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
$30 stock to buy before Starlink goes public (WATCH NOW!) (Ad)

In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s known for playing his cards “close to the vest”… Is going to give you the name and ticker symbol of a company he believes will skyrocket thanks to the coming Starlink IPO…tc pixel

Click here to watch this short 3-minute video now.
11/06/2025 3:14 PM
Privia Health Group (1759655) Filer
Form S-3ASR
11/06/2025 7:45 AM
Privia Health Group (1759655) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2025 5:09 AM
Privia Health Group (1759655) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2025 10:44 AM
FMR LLC (315066) Filed by
Privia Health Group (1759655) Subject
Form SCHEDULE 13G/A
10/28/2025 4:11 PM
Privia Health Group (1759655) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2025 3:23 PM
Boehler Adam (1982325) Filed by
Privia Health Group (1759655) Subject
Form SCHEDULE 13G/A
09/23/2025 3:12 PM
Privia Health Group (1759655) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2025 5:04 AM
Boehler Adam (1982325) Filed by
Privia Health Group (1759655) Subject
Form SCHEDULE 13G
08/07/2025 5:10 AM
Privia Health Group (1759655) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2025 11:11 AM
FMR LLC (315066) Filed by
Privia Health Group (1759655) Subject
Form SCHEDULE 13G/A
07/08/2025 8:03 AM
Privia Health Group (1759655) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2025 3:57 PM
Morris Matthew Shawn (1401958) Reporting
Privia Health Group (1759655) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025 3:58 PM
Privia Health Group (1759655) Issuer
Ryu Jaewon (1869233) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025 4:00 PM
Maryland Patricia Anne (1798468) Reporting
Privia Health Group (1759655) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025 4:01 PM
Kimmet Pamela O (1589981) Reporting
Privia Health Group (1759655) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025 4:02 PM
COCOZZA NANCY G (1232953) Reporting
Privia Health Group (1759655) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025 4:03 PM
Privia Health Group (1759655) Issuer
WICHMANN DAVID S (1268489) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025 4:04 PM
KING DAVID P (1275654) Reporting
Privia Health Group (1759655) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025 4:11 PM
McCarthy Thomas A (1500886) Reporting
Privia Health Group (1759655) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Privia Health Group SEC Filings - Frequently Asked Questions

Privia Health Group (PRVA) has submitted 381+ filings to the SEC since 2019. You can browse the complete history or filter by form type using the tools above.

Privia Health Group's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Privia Health Group's financial statements page.

The most recent filing was a Form 4 submitted on May 13, 2026. This was an insider ownership change filed by 4 - Privia Health Group, Inc. (0001759655) (Issuer).

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:PRVA) was last updated on 5/21/2026 by MarketBeat.com Staff.
From Our Partners